Associating liver partition and portal vein ligation for staged hepatectomy offers high oncological feasibility with adequate patient safety: A prospective study at a single center

Annals of Surgery

Volumn 261, Issue 4, 2015, Pages 723-732

  Alvarez, Fernando A ^a   Ardiles, Victoria ^a   De Santibañes, Martin ^a   Pekolj, Juan ^a   De Santibañes, Eduardo ^a  

^a HOSPITAL ITALIANO DE BUENOS AIRES   (Argentina)

Author keywords

ALPPS; Hepatectomy; Hypertrophy; Liver failure; Scintigraphy

Indexed keywords

ADULT; AGED; ARTICLE; BILE DUCT CARCINOMA; BODY MASS; CANCER CHEMOTHERAPY; CANCER MORTALITY; CANCER RECURRENCE; CANCER STAGING; CHARLSON COMORBIDITY INDEX; CLINICAL ARTICLE; CLINICAL TRIAL; COLORECTAL LIVER METASTASIS; DISEASE FREE SURVIVAL; FEMALE; FUNCTIONAL ASSESSMENT; HUMAN; LENGTH OF STAY; LIVER CELL CARCINOMA; LIVER FAILURE; LIVER FIBROSIS; LIVER FUNCTION; LIVER HYPERTROPHY; LIVER PARENCHYMA; LIVER RESECTION; MALE; METASTATIC COLORECTAL CANCER; NEUROENDOCRINE TUMOR; NUCLEAR MAGNETIC RESONANCE IMAGING; OBSERVATIONAL STUDY; OVERALL SURVIVAL; PATIENT SAFETY; PATIENT SELECTION; PORTAL VEIN; POSTOPERATIVE COMPLICATION; PREOPERATIVE EVALUATION; PRIMARY TUMOR; PRIORITY JOURNAL; PROSPECTIVE STUDY; SURGICAL RISK; VEIN LIGATION; ADVERSE EFFECTS; COHORT ANALYSIS; COLORECTAL TUMOR; FEASIBILITY STUDY; FOLLOW UP; HEPATOMEGALY; LAPAROSCOPY; LIGATION; LIVER; LIVER NEOPLASMS; MIDDLE AGED; MORTALITY; ORGAN SIZE; PATHOLOGY; PROCEDURES; REOPERATION; SECONDARY; STATISTICS AND NUMERICAL DATA; SURVIVAL RATE; TREATMENT OUTCOME; TUMOR RECURRENCE; VASCULAR SURGERY; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; COHORT STUDIES; COLORECTAL NEOPLASMS; DISEASE-FREE SURVIVAL; FEASIBILITY STUDIES; FEMALE; FOLLOW-UP STUDIES; HEPATECTOMY; HEPATOMEGALY; HUMANS; LAPAROSCOPY; LENGTH OF STAY; LIGATION; LIVER; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; NEUROENDOCRINE TUMORS; ORGAN SIZE; PATIENT SAFETY; PORTAL VEIN; PROSPECTIVE STUDIES; REOPERATION; SURVIVAL RATE; TREATMENT OUTCOME; VASCULAR SURGICAL PROCEDURES;

EID: 84928760082     PISSN: 00034932     EISSN: 15281140     Source Type: Journal    
DOI: 10.1097/SLA.0000000000001046     Document Type: Article

References (45)

1. Agrawal S, Belghiti J. Oncologic resection for malignant tumors of the liver. Ann Surg. 2011;253:656-665.
2. Clavien PA, Petrowsky H, De Oliveira M, et al. Strategies for safer liver surgery and partial liver transplantation. N Engl J Med. 2007;356:1545-1559.
3. Ferrero A, Vigano L, Polastri R, et al. Postoperative liver dysfunction and future remnant liver: where is the limit? Results of a prospective study. World J Surg. 2007;31:1643-1651.
4. Kishi Y, Abdalla EK, Chun YS, et al. Three hundred and one consecutive extended right hepatectomies: evaluation of outcome based on systematic liver volumetry. Ann Surg. 2009;250:540-548.
5. Mise Y, Sakamoto Y, Ishizawa T, et al. A worldwide survey of the current daily practice in liver surgery. Liver Cancer. 2013;2:55-66.
6. Liu H, Zhu S. Present status and future perspectives of preoperative portal vein embolization. Am J Surg. 2009;197:686-690.
7. Wicherts DA, Miller R, de Haas RJ, et al. Long-term results of two-stage hepatectomy for irresectable colorectal cancer liver metastases. Ann Surg. 2008;248:994-1005.
8. Jaeck D, Oussoultzoglou E, Rosso E, et al. A two-stage hepatectomy procedure combined with portal vein embolization to achieve curative resection for initially unresectable multiple and bilobar colorectal liver metastases. Ann Surg. 2004;240:1037-1049.
9. Schnitzbauer AA, Lang SA, Goessmann H, et al. Right portal vein ligation combined with in situ splitting induces rapid left lateral liver lobe hypertrophy enabling two-staged extended right hepatic resection in small-for-size settings. Ann Surg. 2012;255:405-414.
10. de Santibañes E, Clavien PA. Playing Play-Doh to prevent postoperative liver failure: the "ALPPS" approach. Ann Surg. 2012;255:415-417.
11. Clavien PA, Lillemoe KD. Note from the editors on the ALPPS e-Letters-tothe- Editor. Ann Surg. 2012;256:552.
12. Li J, Girotti P, Königsrainer I, Ladurner R, et al. ALPPS in right trisectionectomy: a safe procedure to avoid postoperative liver failure?. J Gastrointest Surg. 2013;17:956-961.
13. Dokmak S, Belghiti J. Which limits to the "ALPPS" approach?. Ann Surg. 2012;256:e6.
14. Knoefel WT, Gabor I, Rehders A, et al. In situ liver transection with portal vein ligation for rapid growth of the future liver remnant in two-stage liver resection. Br J Surg. 2013;100:388-394.
15. Kokudo N, Shindoh J. How can we safely climb the ALPPS?. Updates Surg. 2013;65:175-177.
16. Torres OJ, Fernandes Ede S, Oliveira CV, et al. Associating liver partition and portal vein ligation for staged hepatectomy (ALPPS): the Brazilian experience. Arq Bras Cir Dig. 2013;26:40-43.
17. Worldwide registry of associating liver partition and portal vein ligation for staged hepatectomy (ALPPS). Data management system. Available at: www. alpps.net. Accessed June 15, 2014.
18. Ulla M, Ardiles V, Levy-Yeyati E, et al. New surgical strategy to induce liver hypertrophy: role of MDCT-volumetry to monitor and predict liver growth. Hepatogastroenterology. 2013;60:337-342.
19. Vauthey JN, Abdalla EK, Doherty DA, et al. Body surface area and body weight predict total liver volume in Western adults. Liver Transpl. 2002;8: 233-240.
20. Alvarez FA, Ardiles V, Sanchez Claria R, et al. Associating liver partition and portal vein ligation for staged hepatectomy (ALPPS): tips and tricks. J Gastrointest Surg. 2013;17:814-821.
21. Pekolj J, Alvarez FA, Ardiles V, et al. Pure laparoscopic associating liver partition and portal vein ligation for staged hepatectomy (ALPPS): a new approach for an emerging surgical technique. JSLS. 2014. In press.
22. de Santibañes M, Alvarez FA, Santos FR, et al. The associating liver partition and portal vein ligation for staged hepatectomy approach using only segments I and IV as future liver remnant. J Am Coll Surg. 2014;219:e5-e9.
23. Strasberg SM, Phillips C. Use and dissemination of the Brisbane 2000 nomenclature of liver anatomy and resections. Ann Surg. 2013;257: 377-382.
24. Clavien PA, Barkun J, de Oliveira ML, et al. The Clavien-Dindo classification of surgical complications: five-year experience. Ann Surg. 2009;250: 187-196.
25. Paugam-Burtz C, Janny S, Delefosse D, et al. Prospective validation of the "fifty-fifty" criteria as an early and accurate predictor of death after liver resection in intensive care unit patients. Ann Surg. 2009;249:124-128.
26. Rahbari NN, Garden OJ, Padbury R, et al. Posthepatectomy liver failure: a definition and grading by the International Study Group of Liver Surgery (ISGLS). Surgery. 2011;149:713-724.
27. Cauchy F, Aussilhou B, Dokmak S, et al. Reappraisal of the risks and benefits of major liver resection in patients with initially unresectable colorectal liver metastases. Ann Surg. 2012;256:746-754.
28. Shindoh J, Vauthey JN, Zimmitti G, et al. Analysis of the efficacy of portal vein embolization for patients with extensive liver malignancy and very low future liver remnant volume, including a comparison with the associating liver partition with portal vein ligation for staged hepatectomy approach. J Am Coll Surg. 2013;217:126-133.
29. Hoekstra LT, van Lienden KP, Doets A, et al. Tumor progression after preoperative portal vein embolization. Ann Surg. 2012;256:812-817.
30. Simoneau E1, Aljiffry M, Salman A, et al. Portal vein embolization stimulates tumour growth in patients with colorectal cancer liver metastases. HPB (Oxford). 2012;14:461-468.
31. Brouquet A, Abdalla EK, Kopetz S, et al. High survival rate after two-stage resection of advanced colorectal livermetastases: response-based selection and complete resection define outcome. J Clin Oncol. 2011;29:1083-1090.
32. Tsai S, Marques HP, de Jong MC, et al. Two-stage strategy for patients with extensive bilateral colorectal liver metastases. HPB (Oxford). 2010;12:262-269.
33. Robertson DJ, Stukel TA, Gottlieb DJ, et al. Survival after hepatic resection of colorectal cancer metastases: a national experience. Cancer. 2009;115:752-759.
34. Adam R, Laurent A, Azoulay D, et al. Two-stage hepatectomy: a planned strategy to treat irresectable liver tumors. Ann Surg. 2000;232: 777-785.
35. Alvarez FA, Ardiles V, de Santibañes E. The ALPPS approach for the management of colorectal carcinoma liver metastases. Curr Colorectal Cancer Rep. 2013;9:168-177.
36. Lau L, Christophi C, Muralidharan V. Intraoperative functional liver remnant assessment with indocyanine green clearance: another toehold for climbing the "ALPPS." Ann Surg. 2015;261:e43-e45.
37. Allard MA, Adam R, Bucur PO, et al. Posthepatectomy portal vein pressure predicts liver failure and mortality after major liver resection on noncirrhotic liver. Ann Surg. 2013;258:822-829.
38. Asencio JM,Vaquero J, Olmedilla L, et al. "Small-for-flow" syndrome: shifting the "size" paradigm. Med Hypotheses. 2013;80:573-577.
39. Schadde E, Ardiles V, Slankamenac K, et al. ALPPS offers a better chance of complete resection in patients with primarily unresectable liver tumors compared with conventional-staged hepatectomies: results of a multicenter analysis. World J Surg. 2014;38:1510-1519.
40. Lam VW, Laurence JM, Johnston E, et al. A systematic review of two-stage hepatectomy in patients with initially unresectable colorectal liver metastases. HPB (Oxford). 2013;15:483-491.
41. Machado MA, Makdissi FF, Surjan RC. Totally laparoscopicALPPS is feasible and may be worthwhile. Ann Surg. 2012;256:e13.
42. Conrad C, Shivathirthan N, Camerlo A, et al. Laparoscopic portal vein ligation with in situ liver split for failed portal vein embolization. Ann Surg. 2012;256:e14-e15.
43. Schadde E, Clavien PA. Reply to letter: "Accelerated liver hypertrophy: ALPPS and more!" Ann Surg. 2015;261:e46-e47.
44. McCulloch P, Altman DG, Campbell WB, et al. Surgical innovation and evaluation 3: no surgical innovation without evaluation-the IDEAL recommendations. Lancet. 2009;374:1105-1112.
45. Figueras J, Belghiti J. The ALPPS approach: should we sacrifice basic therapeutic rules in the name of innovation? World J Surg. 2014;38: 1520-1521.